Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
6.70 Up 0.32(5.02%) 3:59PM EDT
Prev Close:6.38
Open:6.33
Bid:6.70 x 14700
Ask:6.71 x 4300
1y Target Est:12.14
Beta:2.94
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:6.25 - 6.73
52wk Range:3.84 - 7.49
Volume:633,318
Avg Vol (3m):403,017
Market Cap:403.45M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNSS

Comparison

Symbol% ChgMkt Cap
SNSSUp 5.02%403.45M
AZNDown 0.05%93.92B
PFEDown 0.49%192.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):48.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.72
Quarterly EPS Est (Jun-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback